Fulgent Genetics, Inc.
FLGT
$14.85
$0.221.50%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -297.72% | 54.89% | -117.65% | 14.35% | 95.41% |
| Total Depreciation and Amortization | -1.29% | 1.99% | -1.61% | -11.17% | -5.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.53% | -51.01% | 125.45% | 19.81% | -93.25% |
| Change in Net Operating Assets | -542.98% | 109.26% | -1,391.17% | -299.49% | 58.23% |
| Cash from Operations | -412.35% | 171.62% | -804.11% | -160.98% | 67.53% |
| Capital Expenditure | -31.82% | 69.03% | 47.27% | -16.32% | -21.64% |
| Sale of Property, Plant, and Equipment | -- | -92.11% | -100.00% | -99.22% | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 168.14% | -25.02% | 197.71% | 174.78% | -186.29% |
| Cash from Investing | 140.63% | 112.40% | 631.16% | 158.77% | -213.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 35.29% | 35.29% | 85.38% | 32.67% | 93.11% |
| Issuance of Common Stock | -98.04% | -- | -- | -- | -- |
| Repurchase of Common Stock | -84.71% | 17.17% | -368.75% | -454.06% | 98.99% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -63.30% | 21.52% | -130.19% | -298.00% | 98.74% |
| Foreign Exchange rate Adjustments | 155.97% | -90.45% | 144.44% | 115.94% | -192.41% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,227.40% | 529.20% | 97.42% | 128.36% | -121.63% |